Chiral Total Synthesis of High-purity Orlistat API market was valued at USD 384 million in 2025 and is projected to reach USD 794 million by 2034, exhibiting a remarkable CAGR of 10.8% during the forecast period.  Chiral Total Synthesis of High-purity Orlistat API represents a breakthrough manufacturing paradigm for the globally recognised weight‑loss active pharmaceutical ingredient. By...